Julian A. Gatta

发表

Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3

L. Rice, V. Shanmugasundaram, R. Bonomo, 2012, Antimicrobial Agents and Chemotherapy.

Reclaiming the Efficacy of β-Lactam–β-Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime

R. Bonomo, Yan Xu, S. Chilakala, 2014, Antimicrobial Agents and Chemotherapy.

Reclaiming the Efﬁcacy of (cid:2) -Lactam– (cid:2) -Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime

Yan Xu, R. Bonomo, S. Chilakala, 2014 .

Exploring the Role of the (cid:2) -Loop in the Evolution of Ceftazidime Resistance in the PenA (cid:3) -Lactamase from Burkholderia multivorans , an Important Cystic Fibrosis Pathogen

J. Lipuma, K. Papp-Wallace, M. Taracila, 2017 .

Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen

R. Bonomo, J. Lipuma, K. Papp-Wallace, 2016, Antimicrobial Agents and Chemotherapy.

Exposing a β-Lactamase “Twist”: the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase

R. Bonomo, H. Schweizer, K. Papp-Wallace, 2015, Antimicrobial Agents and Chemotherapy.

Insights into β-Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance Determinants*

R. Bonomo, K. Papp-Wallace, M. Taracila, 2013, The Journal of Biological Chemistry.

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.

R. Bonomo, M. Falleni, J. Lipuma, 2017, ACS infectious diseases.

Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans

G. Sutton, D. Fouts, Indresh Singh, 2018, Diagnostic microbiology and infectious disease.

A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.

M. Page, R. Bonomo, A. Hujer, 2014, The Journal of antimicrobial chemotherapy.

Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

R. Bonomo, M. Jacobs, S. Bajaksouzian, 2015, Diagnostic microbiology and infectious disease.

Evaluation of a Commercial Microarray System for Detection of SHV-, TEM-, CTX-M-, and KPC-Type β-Lactamase Genes in Gram-Negative Isolates

L. Rice, R. Bonomo, K. Hujer, 2010, Journal of Clinical Microbiology.

Reclaiming the Efﬁcacy of (cid:2) -Lactam– (cid:2) -Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime

Yan Xu, R. Bonomo, S. Chilakala, 2014 .

Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3

L. Rice, V. Shanmugasundaram, R. Bonomo, 2012, Antimicrobial Agents and Chemotherapy.

Early Insights into the Interactions of Different (cid:1) -Lactam Antibiotics and (cid:1) -Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3

V. Shanmugasundaram, J. Buynak, Marion J. Skalweit, 2012 .